Conneqt Health Limited · ASX:CQT
Conneqt Health — Shareholder Meeting (September 2026)
26 slides from Conneqt Health's shareholder meeting presentation, Sep 15, 2026
Slide 1: ASX Announcement: CONNEQT EGM Presentation
ASX ANNOUNCEMENT 15 September 2026 ASX ANNOUNCEMENT CONNEQT EGM Presentation CONNEQT Health Limited (ASX: CQT) (“CONNEQT” or “the Company”) advises that an Extraordinary General Meeting was held today, 15 September 2026. The presentation slides from the meeting (presented in USD) are attached to thi
Slide 2: CONNEQT can make premature heart attacks a thing of the past
“Man is as Old as his arteries” - Thomas Sydenham CONNEQT can make premature heart attacks a thing of the past 1
Slide 3: Every 2 minutes a working age adult experiences a heart attack
Every 2 minutes a 44 $35K-$90K first-year direct medical costs working age days Up to adult experiences away from work a heart attack ~$10K out-of-pocket exposure Return to work after myocardial infarction: A systematic review 2
Slide 4: 2 in 3 adults show early vascular aging, yet arterial health remains overlooked
2 in 3 adults show early vascular aging, yet arterial health remains Flexible Artery Stiff Artery overlooked. 50% reduction in CVD risk 2-3X increase in CVD risk (Framingham Heart Study) 3
Slide 5: Arterial health is increasingly treatable
15% to 60% clinical risk reduction across modern therapeutic classes. Arterial health is increasingly GLP-1s Proven in SELECT trial PCSK9 Inhibitors Proven in FOURIER trial Inclisiran Proven in ORION trial treatable 4
Slide 6: Existing tools don't capture aging arteries
Existing tools don’t capture aging arteries S Y S T E M V I E W T H E H I D D E N R E A L I T Y Patient: Maria, 48 Actual Biology: The arteries of an 82-year-old, premature coronary disease AHA PREVENT calculator Reclassified Result: 2.1% 13.4% LOW RISK HIGH RISK A traditional blood-pressure measure
Slide 7: ... a 2-minute assessment can
... a 2-minute assessment can \isiizzs3|
Slide 8: By applying advanced algorithms to the familiar blood pressure measurement
By applying advanced algorithms to the familiar blood pressure measurement Why home Why in-clinic Two Markets, health Matters Matters One Platform • Visibility & • Clinical Credibility • Enterprise builds Engagement credibility and • Distribution & Validation strategic leverage. • Consumer • Institu
Slide 9: Measurement: See arterial function without requiring imaging
See arterial function without requiring imaging Five biomarkers show how arteries respond to each heartbeat Measurement Central Blood Central Pulse Pulse Pressure Augmentation Augmentation Pressure Pressure Amplification Pressure Index Threshold Each 10mmHg Each 10% >130 mmHg >50 mmHg <130% increase
Slide 10: CONNEQT pioneered the gold standard SphygmoCor technology
SphygmoCor® CONNEQT Our patented Pulse Wave Analysis technology non-invasively pioneered extracts functional biomarkers of vascular aging that predicts cardiovascular events. the gold standard 20+ 3,200+ technology Years of R&D Peer-Reviewed Studies 9
Slide 11: Trusted by the World's Best in Healthcare & Science
Trusted by the World’s Best in Healthcare & Science
Slide 12: De-risked business ready to scale
ENTERPRISE De-risked business ready to scale CONSUMER
Slide 13: Consumer and Enterprise pricing
CONSUMER ENTERPRISE Yearly Plan Monthly Plan $199.99 $24.99 Cash pay $8-15/report 10 Pack - $99 Reimbursable CPT 93050 Recurring One-time $289 per unit $2,500 setup 12
Slide 14: Consumer: 0 to ~$4M run rate in six quarters
Consumer: 0 to ~$4M run rate in six quarters 13X $1,000,000 Device Sale Subscription $900,000 $800,000 $700,000 $600,000 $500,000 $400,000 launch $300,000 $200,000 $100,000 $0 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 preorder *Chart reflects cash receipts at order. GAAP revenue is rec
Slide 15: Enterprise: one-time sales into recurring revenue
Enterprise: one-time sales into recurring revenue $6,100 in year 1, then $3,600 ARR + overage revenue as utilization grows Clinic economics One-time model Subscription model Year-one revenue $6,500 $6,100 Base ARR thereafter — $3,600 Usage-based overages — Additional upside Three-year base revenue $
Slide 16: Health spending is moving toward measurement, prevention and longitudinal management
Health spending is moving toward measurement, prevention and longitudinal management 15
Slide 17: 84% of U.S. consumers say wellness is a top or important priority
MARKET TAILWIND 84% of U.S. consumers say wellness is a top or important priority $600B $500B 4–5% estimated annual >$500B category growth $400B >$450B The reported figures are directional lower-bound estimates from separate $300B McKinsey survey years—not a standardized spending series. $200B $100B
Slide 18: ACO performance payments rose 32% year over year
MARKET TAILWIND ACO performance payments rose 32% year over year $5.0B +32% Medicare Shared $4.0B $4.1B Savings Program Value-based care is putting more $3.0B economic weight behind prevention, $3.1B risk identification and longitudinal management. $2.0B Calculation: $4.1B ÷ $3.1B − 1 = 32.3% $1.0B
Slide 19: 20% of employers plan to increase well-being investment
MARKET TAILWIND 20% of employers plan to increase well-being investment 2025 Investment Plans 20 73 7 93% plan to maintain or increase investment Survey base: 131 employers Increase Maintain Other / not stated Source: Business Group on Health, 2025 Employer Well-being Strategy Survey (n=131).
Slide 20: DPC and concierge practice sites grew 83% in five years
MARKET TAILWIND DPC and concierge practice sites grew 83% in five years +83% 3,036 3000 U.S. practice sites, 2018–2023 A rapidly expanding premium- 2500 primary-care channel creates more potential entry points for routine arterial assessment. 2000 1,658 1500 2018 2019 2020 2021 2022 2023 Source: Hea
Slide 21: From preventive screening to $1B recurring revenue
From preventive screening to $1B recurring revenue Consumer demand High-intent entry channel Population-scale opportunity Health-conscious consumers already pay to Advanced-testing, understand risk concierge and Annual screening earlier functional- for 105 million medicine practices working age Amer
Slide 22: Every hidden signal became a category
Every hidden signal became a category. Arterial is the last one, and the biggest Metabolic Health US ~$300M* Blood Biomarkers US $2.5B* Whoop and Oura are Performance Fitness US $10B* now adding clinical blood-testing layers, reaching for the validation CONNEQT Sleep Monitoring US $11B* already owns
Slide 23: From validated technology to a scalable category
From validated technology to a scalable category Investment builds the cloud, device, mobile and commercial infrastructure required to make arterial health routinely measured – and recurring revenue. Consumer and 1 SphygmoCor Cloud 2 Connected device platform 3 clinical experience Cloud-native algor
Slide 24: CONNEQT Arterial Health Ecosystem
CONNEQT CONNEQT Pulse Arterial Health Ecosystem Legacy, doesn’t speak cloud and we are exploring how to do so w/o triggering regulatory review. SphygmoCor XCEL SphygmoCor® Cloud Pulse + all future devices Analytics store data in the Data Lake Data Lake CONNEQT V2 XCEL V2 Algorithm V2+ will do all bi
Slide 25: Proven operators. Real cardiology. Aligned ownership.
Proven operators. Real cardiology. Aligned ownership. Catherine Liao Oliver Shay Dr. Sanjeev Bhavnani Scott Finneran Craig R. Cooper Niall Cairns Chief Strategy & Chief Digital Officer Medical Officer – Cardiology VP Engineering CEO & Co-Founder Executive Chairman Commercial Officer & Co-Founder Blu
Slide 26: Thank You
Thank You CONNEQT Health
CONNEQT Health — Shareholder Meeting (September 2026) on 6ix